Social Media Ideas for Big Pharma

<![CDATA[340B Under Pressure: Inside Pharma's Push for Greater Clarity]]>

Pharma’s $500B patent problem will come in waves — not as a cliff

Merck is the most vulnerable to generic competition in the short term, but AbbVie, Johnson & Johnson, Sanofi and others will also grapple with patent losses in the years to com...

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

4 largest PBMs control 75% of U.S. market, AMA finds

The four largest PBMs by national market share were OptumRx (23%), Express Scripts (23%), CVS/Caremark (18%) and Prime Therapeutics (11%).

<![CDATA[Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments]]>

<![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

<![CDATA[Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts]]>

AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot

The conflict of interest that discloses as nothing

With 66 percent of U.S. adults, some 131 million people, now taking prescription drugs, and with Medicare drug spending running into the hundreds of billions, it is worth asking ho...

<![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]>

<![CDATA[ The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals]]>

<![CDATA[MFN Is an Offer Pharma Can’t Refuse]]>

<![CDATA[Nine European Drugmakers Warn the Continent Risks Losing the Pharma Investment Race: Report ]]>

<![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>

PhRMA launches new legal challenge as CMS brings 'most favored nation' pricing to Medicare Part B

As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, the pharmaceutical industry’s top lobbying group is pushing bac...

European drugmakers say they are ‘losing ground’ to US and Chinese rivals

Some of continent’s biggest pharma firms write to national leaders calling for action to safeguard their futuresSome of Europe’s biggest pharmaceutical companies have said the cont...

<![CDATA[Where Most Pharma Companies Still Have Meaningful Gaps in Their Supply Chains: LogiPharma 2026]]>

<![CDATA[Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report ]]>

<![CDATA[InnoCare Enters $3.35 Billion Research Collaboration and License Agreement with Eli Lilly]]>

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

<![CDATA[A Steadying Trajectory: Biopharma Review and Outlook]]>

<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>